These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8555032

  • 1. Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.
    Boffa MJ, Chalmers RJ, Haboubi NY, Shomaf M, Mitchell DM.
    Br J Dermatol; 1995 Nov; 133(5):774-8. PubMed ID: 8555032
    [Abstract] [Full Text] [Related]

  • 2. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
    Kumar B, Saraswat A, Kaur I.
    Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
    [Abstract] [Full Text] [Related]

  • 3. Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate.
    van Dooren-Greebe RJ, Kuijpers AL, Termorshuizen F, van de Kerkhof PC.
    Acta Derm Venereol; 1995 Sep; 75(5):393-6. PubMed ID: 8615062
    [Abstract] [Full Text] [Related]

  • 4. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.
    Langman G, Hall PM, Todd G.
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1395-401. PubMed ID: 11851839
    [Abstract] [Full Text] [Related]

  • 5. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA, Aithal GP.
    Am J Clin Dermatol; 2005 Dec; 6(6):357-63. PubMed ID: 16343024
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC, Cássia FF, Lamy F, Chagas VL, Ramos-e-Silva M.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [Abstract] [Full Text] [Related]

  • 7. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
    Berends MA, Snoek J, de Jong EM, van de Kerkhof PC, van Oijen MG, van Krieken JH, Drenth JP.
    Aliment Pharmacol Ther; 2006 Sep 01; 24(5):805-11. PubMed ID: 16918884
    [Abstract] [Full Text] [Related]

  • 8. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD, Maddox AJ, Green CA, Tatnall F, Schofield JK, Stott DJ.
    Br J Dermatol; 2005 Mar 01; 152(3):451-8. PubMed ID: 15787813
    [Abstract] [Full Text] [Related]

  • 9. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
    Aithal GP, Haugk B, Das S, Card T, Burt AD, Record CO.
    Aliment Pharmacol Ther; 2004 Feb 15; 19(4):391-9. PubMed ID: 14871278
    [Abstract] [Full Text] [Related]

  • 10. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB, Arnold GL, Gowans JD, Kaplan MM.
    Dig Dis Sci; 1985 Feb 15; 30(2):104-9. PubMed ID: 3967557
    [Abstract] [Full Text] [Related]

  • 11. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
    Nyfors A, Poulsen H.
    Acta Pathol Microbiol Scand A; 1976 May 15; 84(3):262-70. PubMed ID: 1274591
    [Abstract] [Full Text] [Related]

  • 12. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
    Boffa MJ, Smith A, Chalmers RJ, Mitchell DM, Rowan B, Warnes TW, Shomaf M, Haboubi NY.
    Br J Dermatol; 1996 Oct 15; 135(4):538-44. PubMed ID: 8915142
    [Abstract] [Full Text] [Related]

  • 13. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
    Chalmers RJ, Kirby B, Smith A, Burrows P, Little R, Horan M, Hextall JM, Smith CH, Klaber M, Rogers S.
    Br J Dermatol; 2005 Mar 15; 152(3):444-50. PubMed ID: 15787812
    [Abstract] [Full Text] [Related]

  • 14. Hodgkin's lymphoma in a patient of psoriasis treated with long-term, low-dose methotrexate therapy.
    Khopkar U, Bhor U.
    Indian J Dermatol Venereol Leprol; 2008 Mar 15; 74(4):379-82. PubMed ID: 18797063
    [Abstract] [Full Text] [Related]

  • 15. Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics.
    Nyfors A.
    Acta Pathol Microbiol Scand A; 1977 Jul 15; 85(4):511-8. PubMed ID: 899789
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S, Krishna V, Kanwar AJ.
    Clin Exp Dermatol; 2012 Oct 15; 37(7):729-34. PubMed ID: 22830389
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up.
    Zachariae H, Søgaard H, Heickendorff L.
    Dermatology; 1996 Oct 15; 192(4):343-6. PubMed ID: 8864370
    [Abstract] [Full Text] [Related]

  • 18. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
    Zachariae H, Grunnet E, Sogaard H.
    Acta Derm Venereol; 1975 Oct 15; 55(4):291-6. PubMed ID: 52258
    [Abstract] [Full Text] [Related]

  • 19. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ, Kuijpers AL, Buijs WC, Kniest PH, Corstens FH, Nagengast FM, de Boo T, Willems JL, Duller P, van de Kerkhof PC.
    Br J Dermatol; 1996 Mar 15; 134(3):481-7. PubMed ID: 8731673
    [Abstract] [Full Text] [Related]

  • 20. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.
    Zachariae H, Heickendorff L, Søgaard H.
    Br J Dermatol; 2001 Jan 15; 144(1):100-3. PubMed ID: 11167689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.